Mufg Securities Americas Inc. Acquires Shares of 1,070 Axon Enterprise, Inc. (NASDAQ:AXON)

Mufg Securities Americas Inc. acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,070 shares of the biotechnology company's stock, valued at approximately $636,000.

Other hedge funds also recently modified their holdings of the company. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise in the 4th quarter valued at about $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise during the fourth quarter worth about $45,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise during the fourth quarter worth about $53,000. GPS Wealth Strategies Group LLC grew its holdings in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares during the period. Finally, Berbice Capital Management LLC bought a new position in Axon Enterprise during the fourth quarter worth about $59,000. Institutional investors own 79.08% of the company's stock.

Insider Activity

In other news, President Joshua Isner sold 9,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the sale, the president now directly owns 308,714 shares in the company, valued at approximately $210,947,363.34. The trade was a 2.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 23,764 shares of company stock worth $14,856,635. Corporate insiders own 4.40% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on AXON shares. The Goldman Sachs Group lifted their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday. Needham & Company LLC lifted their price target on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays lifted their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Finally, Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise has a consensus rating of "Moderate Buy" and a consensus price target of $652.73.

Axon Enterprise Stock Performance

AXON stock traded up $4.79 during mid-day trading on Friday, hitting $733.18. 419,101 shares of the company were exchanged, compared to its average volume of 759,084. The business has a 50 day simple moving average of $584.61 and a 200-day simple moving average of $595.70. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $57.08 billion, a PE ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $735.68.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same period last year, the business posted $1.15 earnings per share. The business's revenue for the quarter was up 31.3% compared to the same quarter last year. On average, equities analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.